Visioneering Technologies, Inc. announced the appointment of Dr. Juan Carlos Aragón as Chief Executive Officer, effective 1 October 2023. Dr. Aragón brings over 30 years of leadership in the vision care industry to VTI. His experience includes senior executive leadership positions in several large international vision care companies, and managing divisions for the Americas, Asia Pacific, and Europe.

Most recently, he was President of CooperVision (?CV?) Specialty EyeCare, which incorporates CV?s soft custom and rigid gas permeable contact lens product offerings, including orthokeratology, scleral lenses, and myopia management products for global markets, including China. In the previous 23 years, Dr. Aragón has held several senior positions within CooperVision and a predecessor company. He also held positions within CIBA Vision, a predecessor company to Alcon, and with Bausch + Lomb.

Dr. Aragón earned his optometry degree from the Superior School of Medicine of the National Polytechnic Institute in Mexico City. Dr. Aragón is a former board member and former Chair of the Global Myopia Awareness Coalition (GMAC), a diverse group of leading companies working together to protect children from the effects of myopia. His leadership in and service to GMAC highlights Dr. Aragón's dedication to vision care and the respect the industry has for his capabilities.

He also volunteers as Chairman of the Board of Optometry Giving Sight and has been a board member of the Brien Holden Foundation, the International Agency for the Prevention of Blindness, and Vision Aid Overseas (now Vision Action). He was also a Board Member of Sight Glass Vision, now a Joint Venture of CooperVision and Essilor/Luxottica.